Lynk Pharmaceuticals Co., Ltd

This study tested whether a new ointment called LNK01004 can safely improve symptoms of atopic dermatitis (eczema) in adults. 75 people with moderate-to-severe eczema applied either a low dose, high dose, or a placebo cream twice daily for 8 weeks. The main goal was to see how mu…

This study tested an experimental drug called LNK01001 in 356 adults with moderate to severe atopic dermatitis (eczema) that didn't improve enough with standard creams or other treatments. Participants received either the drug or a placebo pill for 16 weeks. The main goals were t…